Company Filing History:
Years Active: 2023
Title: Innovations of Chung-Hao Chang in Vaccine Development
Introduction
Chung-Hao Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly in enhancing the efficacy of vaccines through innovative approaches.
Latest Patents
Chung-Hao Chang holds a patent for "Vaccines with higher carbohydrate antigen density and novel saponin adjuvant." This invention provides vaccines that comprise carbohydrate antigen conjugated to a diphtheria toxin (DT) as a carrier protein. The unique aspect of this patent is that the ratio of carbohydrate antigen molecules to carrier protein molecules is higher than 5:1. Additionally, the patent discloses a novel saponin adjuvant and methods to inhibit cancer cells by administering an effective amount of the vaccine.
Career Highlights
Chung-Hao Chang is currently associated with Obi Pharma Inc., where he continues to work on groundbreaking research in vaccine technology. His innovative work has the potential to significantly impact public health by improving vaccine effectiveness.
Collaborations
Chung-Hao Chang collaborates with talented individuals such as Wei-Han Lee and Nan-Hsuan Wang, contributing to a dynamic research environment that fosters innovation.
Conclusion
Chung-Hao Chang's work in vaccine development exemplifies the importance of innovation in addressing health challenges. His contributions are paving the way for more effective vaccines and potential cancer therapies.